White Paper
Why Pharmaceutical Industry EHS Audits Are Different
This white paper examines why Environmental, Health & Safety (EHS) audits in pharmaceutical manufacturing differ fundamentally from those in other industries. It explores the integration of EHS with Good Manufacturing Practice (GMP), product quality, contamination control, and patient safety while addressing complex global regulatory requirements. The paper discusses cleanroom management, hazardous pharmaceutical compounds, biosafety, waste classification, exposure assessment, validation, electronic data integrity, and risk management, demonstrating how pharmaceutical EHS audits require specialized expertise that extends well beyond traditional environmental and occupational safety compliance.
